- Home
- WDC vs LLY Comparison
WDC vs LLY Comparison
Compare WDC & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WDC | LLY |
|---|---|---|
| Founded | 1970 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.2B | 979.6B |
| IPO Year | 1999 | 2007 |
Fundamental Metrics
Financial Performance| Metric | WDC | LLY |
|---|---|---|
| Price | $589.58 | $1,210.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 19 |
| Target Price | $281.77 | ★ $1,218.84 |
| AVG Volume (30 Days) | ★ 7.7M | 2.4M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | 0.12% | ★ 0.81% |
| EPS Growth | N/A | ★ 95.99 |
| EPS | ★ 16.05 | 8.26 |
| Revenue | $9,520,000,000.00 | ★ $65,179,000,000.00 |
| Revenue This Year | $32.24 | $27.15 |
| Revenue Next Year | $26.55 | $16.04 |
| P/E Ratio | ★ $41.77 | $136.56 |
| Revenue Growth | N/A | ★ 44.70 |
| 52 Week Low | $62.94 | $623.78 |
| 52 Week High | $799.87 | $1,182.73 |
Technical Indicators
Market Signals| Indicator | WDC | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 72.82 |
| Support Level | $457.44 | $1,032.70 |
| Resistance Level | $602.54 | N/A |
| Average True Range (ATR) | 49.20 | 37.16 |
| MACD | -3.33 | -0.76 |
| Stochastic Oscillator | 34.47 | 97.11 |
Price Performance
Historical ComparisonAbout WDC Western Digital Corporation
Western Digital is a leading vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly, with Western Digital and Seagate being the two largest players. Western Digital designs and manufactures its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.